Literature DB >> 1350577

Neuropharmacologic and behavioral actions of clonidine: interactions with central neurotransmitters.

J J Buccafusco1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1350577     DOI： 10.1016/s0074-7742(08)60691-1

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN： 0074-7742            Impact factor:   3.230


× No keyword cloud information.
  6 in total

1.  New developments in the treatment of attention-deficit/hyperactivity disorder in primary care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 2.  Multifunctional receptor-directed drugs for disorders of the central nervous system.

Authors:  Jerry J Buccafusco
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

3.  Altered thermoregulatory responses to clonidine in streptozotocin-diabetic rats.

Authors:  J M O'Donnell; T Banyasz; T Kovacs
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Changes in acetylcholinesterase activity and muscarinic receptor bindings in mu-opioid receptor knockout mice.

Authors:  Lu-Tai Tien; Lir-Wan Fan; Chiharu Sogawa; Tangeng Ma; Horance H Loh; Ing-Kang Ho
Journal:  Brain Res Mol Brain Res       Date:  2004-07-05

Review 5.  The Cholinergic System as a Treatment Target for Opioid Use Disorder.

Authors:  Kevin P Jensen; Elise E DeVito; Sarah Yip; Kathleen M Carroll; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749

Review 6.  Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.

Authors:  Sydney T Osland; Thomas Dl Steeves; Tamara Pringsheim
Journal:  Cochrane Database Syst Rev       Date:  2018-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.